Skip to main content

Total lymphocyte count and World Health Organization pediatric clinical stage as markers to assess need to initiate antiretroviral therapy among human immunodeficiency virus-infected children in Moshi, Northern Tanzania.

Publication ,  Journal Article
Johnson, OO; Benjamin, DK; Schimana, W; Tillekeratne, LG; Crump, JA; Landman, KZ; Kinabo, GD; Mmbaga, B; Msuya, LJ; Shao, JF; Swai, ME; Cunningham, CK
Published in: Pediatr Infect Dis J
June 2009

BACKGROUND: The World Health Organization (WHO) has recommended the use of clinical staging alone and with total lymphocyte count to identify HIV infected children in need of antiretroviral therapy (ART) in resource-limited settings, when CD4 cell count is not available. METHODS: We prospectively enrolled children obtaining care for HIV infection at the Kilimanjaro Christian Medical Centre Pediatric Infectious Diseases Clinic in Moshi, Tanzania between March 2004 and May 2006 for this cohort study. RESULTS: One hundred ninety two (89.7%) of 214 children met WHO ART initiation criteria based on clinical staging or CD4 cell count. Several low-cost measures identified individuals who met WHO ART initiation criteria to the following degree: WHO stages 3 or 4 had 87.5% (95% CI, 82.8-92.1) sensitivity and, by definition, 100% (CI, 100-100) specificity; WHO recommended advance disease TLC cutoffs: sensitivity = 23.9% (95% CI, 17.3-30.5) specificity = 78.2% (95% CI, 67.3-89.1). Low TLC was a common finding, (50 of 214; 23%); however, it did not improve the sensitivity or specificity of clinical staging in identifying the severely immunosuppressed stage 2 children. Growth failure or use of total lymphocyte counts in isolation were not reliable indicators of severe immunosuppression or need to initiate ART. CONCLUSION: The use of total lymphocyte count does not improve the ability to identify children in need of ART compared with clinical staging alone. Low absolute lymphocyte count did not correlate with severe immunosuppression based on CD4 cell count in this cohort.

Duke Scholars

Published In

Pediatr Infect Dis J

DOI

ISSN

0891-3668

Publication Date

June 2009

Volume

28

Issue

6

Start / End Page

493 / 497

Location

United States

Related Subject Headings

  • World Health Organization
  • Tanzania
  • Sensitivity and Specificity
  • Reproducibility of Results
  • Prognosis
  • Predictive Value of Tests
  • Pediatrics
  • Male
  • Lymphocytes
  • Lymphocyte Count
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Johnson, O. O., Benjamin, D. K., Schimana, W., Tillekeratne, L. G., Crump, J. A., Landman, K. Z., … Cunningham, C. K. (2009). Total lymphocyte count and World Health Organization pediatric clinical stage as markers to assess need to initiate antiretroviral therapy among human immunodeficiency virus-infected children in Moshi, Northern Tanzania. Pediatr Infect Dis J, 28(6), 493–497. https://doi.org/10.1097/INF.0b013e3181950b7f
Johnson, Opemipo O., Daniel K. Benjamin, Werner Schimana, L Gayani Tillekeratne, John A. Crump, Keren Z. Landman, Grace D. Kinabo, et al. “Total lymphocyte count and World Health Organization pediatric clinical stage as markers to assess need to initiate antiretroviral therapy among human immunodeficiency virus-infected children in Moshi, Northern Tanzania.Pediatr Infect Dis J 28, no. 6 (June 2009): 493–97. https://doi.org/10.1097/INF.0b013e3181950b7f.
Johnson OO, Benjamin DK, Schimana W, Tillekeratne LG, Crump JA, Landman KZ, Kinabo GD, Mmbaga B, Msuya LJ, Shao JF, Swai ME, Cunningham CK. Total lymphocyte count and World Health Organization pediatric clinical stage as markers to assess need to initiate antiretroviral therapy among human immunodeficiency virus-infected children in Moshi, Northern Tanzania. Pediatr Infect Dis J. 2009 Jun;28(6):493–497.

Published In

Pediatr Infect Dis J

DOI

ISSN

0891-3668

Publication Date

June 2009

Volume

28

Issue

6

Start / End Page

493 / 497

Location

United States

Related Subject Headings

  • World Health Organization
  • Tanzania
  • Sensitivity and Specificity
  • Reproducibility of Results
  • Prognosis
  • Predictive Value of Tests
  • Pediatrics
  • Male
  • Lymphocytes
  • Lymphocyte Count